HHS Secretary Robert F. Kennedy Jr. (George Walker IV/AP Images)
May 22, 2025 12:14 PM EDTUpdated 04:06 PM
Pharma
FDA+

The ‘MA­HA re­port’: Four key take­aways on vac­cines, med­i­cine and the phar­ma in­dus­try

Max Bayer

Pharma Reporter

The White House re­leased its MA­HA com­mis­sion re­port, de­tail­ing some of the Trump ad­min­is­tra­tion’s top pri­or­i­ties for re­vamp­ing the US health­care sys­tem and is­su­ing a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Meet the ‘first sale’ rule: A cus­toms loop­hole phar­ma com­pa­nies could use to ease tar­iff im­pact

FDA ad­comm votes unan­i­mous­ly against Pfiz­er's prostate can­cer drug com­bo

Post-Hoc: AI bio needs to heed the over­hyped his­to­ry of CRISPR

Sanofi makes $470M move for Vig­il's Alzheimer's drug, while an­oth­er as­set re­turns to Am­gen

Up­dat­ed: Eikon Ther­a­peu­tics cuts staff for the sec­ond time in less than two years

sponsored

Does your sup­ply chain hold up un­der pres­sure for high-risk tem­per­a­ture-crit­i­cal ship­ments?

A service from the Financial Times